XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2020   10,950,289    
Balance at beginning of period at Dec. 31, 2020 $ 223,726 $ 65,395 $ 158,359 $ (28)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 17,709   17,709  
Net unrealized loss on securities available for sale, net of tax (3,819)     (3,819)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 20     20
Net unrealized gain on cash flow hedging derivative instruments, net of tax 2,849     2,849
Comprehensive income (loss) 16,759   17,709 (950)
Cash dividend declared (6,920)   (6,920)  
Equity compensation expense 490 $ 490    
Payment to repurchase common stock (in shares)   (9,561)    
Payment to repurchase common stock (240)   (240)  
Issuance of restricted stock (in shares)   34,689    
Issuance of restricted stock 0      
Proceeds from sale of common stock (in shares)   12,263    
Proceeds from sale of common stock $ 340 $ 340    
Ending balance (in shares) at Jun. 30, 2021 10,987,680 10,987,680    
Balance at end of period at Jun. 30, 2021 $ 234,155 $ 66,225 168,908 (978)
Beginning balance (in shares) at Mar. 31, 2021   10,983,258    
Balance at beginning of period at Mar. 31, 2021 228,184 $ 65,865 163,659 (1,340)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 8,787   8,787  
Net unrealized loss on securities available for sale, net of tax 971     971
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 11     11
Net unrealized gain on cash flow hedging derivative instruments, net of tax (620)     (620)
Comprehensive income (loss) 9,149   8,787 362
Cash dividend declared (3,516)   (3,516)  
Equity compensation expense 201 $ 201    
Payment to repurchase common stock (in shares)   (1,004)    
Payment to repurchase common stock (22)   (22)  
Proceeds from sale of common stock (in shares)   5,426    
Proceeds from sale of common stock $ 159 $ 159    
Ending balance (in shares) at Jun. 30, 2021 10,987,680 10,987,680    
Balance at end of period at Jun. 30, 2021 $ 234,155 $ 66,225 168,908 (978)
Beginning balance (in shares) at Dec. 31, 2021 10,998,765 10,998,765    
Balance at beginning of period at Dec. 31, 2021 $ 245,657 $ 66,940 180,417 (1,700)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 19,702   19,702  
Net unrealized loss on securities available for sale, net of tax (31,077)     (31,077)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 14     14
Net unrealized gain on cash flow hedging derivative instruments, net of tax 146     146
Comprehensive income (loss) (11,215)   19,702 (30,917)
Cash dividend declared (7,278)   (7,278)  
Equity compensation expense 412 $ 412    
Payment to repurchase common stock (in shares)   (8,643)    
Payment to repurchase common stock (276)   (276)  
Issuance of restricted stock (in shares)   27,495    
Issuance of restricted stock 0      
Proceeds from sale of common stock (in shares)   12,619    
Proceeds from sale of common stock $ 385 $ 385    
Ending balance (in shares) at Jun. 30, 2022 11,030,236 11,030,236    
Balance at end of period at Jun. 30, 2022 $ 227,685 $ 67,737 192,565 (32,617)
Beginning balance (in shares) at Mar. 31, 2022   11,024,086    
Balance at beginning of period at Mar. 31, 2022 233,646 $ 67,356 186,324 (20,034)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 9,997   9,997  
Net unrealized loss on securities available for sale, net of tax (12,734)     (12,734)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 5     5
Net unrealized gain on cash flow hedging derivative instruments, net of tax 146     146
Comprehensive income (loss) (2,586)   9,997 (12,583)
Cash dividend declared (3,750)   (3,750)  
Equity compensation expense 195 $ 195    
Payment to repurchase common stock (in shares)   (199)    
Payment to repurchase common stock (6)   (6)  
Proceeds from sale of common stock (in shares)   6,349    
Proceeds from sale of common stock $ 186 $ 186    
Ending balance (in shares) at Jun. 30, 2022 11,030,236 11,030,236    
Balance at end of period at Jun. 30, 2022 $ 227,685 $ 67,737 $ 192,565 $ (32,617)